All lobbying filings

COHERUS BIOSCIENCES

COHERUS BIOSCIENCES filed a Q4 amendment for COHERUS BIOSCIENCES, INC. on March 9, 2026.

Lobbying for COHERUS BIOSCIENCES, INC.

All filings by COHERUS BIOSCIENCES · Everything COHERUS BIOSCIENCES, INC. has reported

Filing · LD-2 quarterly report Q4 amendment

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Mar 9, 2026

Expenses

$80,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Lobbyists on this filing 1

DAVID SANDERS

Previously held: Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 18

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production

Government Issues

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.